The "Aging Science Talks: Science for the Community" daily online seminar series was established in reaction to the cancellation of a myriad of regional, national, and international meetings focused on the biology of aging due to the COVID-19 pandemic. The inability to attend scientific meetings has far-reaching implications for our field, as we lose the ability to 1) disseminate both published and non-published data through talks and posters; 2) network and establish new collaborations to produce innovative science in the aging field; and 3) continue the career development of early career researchers (ECRs). Through these virtual seminars, we hope to offset the negative effects of these canceled meetings. We established the program rapidly using a "lean" approach, making use of existing technologies broadly available at academic institutions. Here, we provide an initial description of how this program was developed and implemented. We discuss advantages and limitations of this approach, including "real-time" participation and the creation of an on/off-line community of inquiry (CoI). In the future, we hope to formally evaluate the success of this program in building engagement, creating a community, and enhancing the development of ECRs, and to capture metrics associated with the continued progress of science. Our approach to building a CoI may be applied across multiple scientific disciplines during this time of uncertainty, and may offer a valuable example of how to continue to advance science during pandemics or similar events.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290191 | PMC |
http://dx.doi.org/10.1016/j.tma.2020.05.002 | DOI Listing |
ACS Appl Mater Interfaces
January 2025
Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw 01-142, Poland.
Ultrasmall micro-light-emitting diodes (μLEDs), sized below 10 μm, are indispensable to create the next-generation augmented and virtual reality (AR/VR) devices. Their high brightness and low power consumption could not only enhance the user experience by providing vivid and lifelike visuals but also extend device longevity. However, a notable challenge emerges: a decrease in efficiency with a reduced size.
View Article and Find Full Text PDFBehav Sci (Basel)
December 2024
Institute of Education, Xiamen University, Xiamen 361005, China.
The authors would like to adjust the author order for the following two reasons: 1 [...
View Article and Find Full Text PDFCroat Med J
December 2024
Haxhi Kamberi, Faculty of Medicine, University of Gjakova "Fehmi Agani", Str. "Sabrije Vokshi-Bija", n.n., 50 000 Gjakova, Kosovo,
Aim: To assess the behavioral correlates of health literacy (HL) among university students of health sciences in Kosovo, irrespective of their sociodemographic characteristics.
Methods: This cross-sectional study, carried out in Kosovo in 2024, enrolled 470 students of health sciences from the universities of Prishtina and Gjakova (86% women; mean age: 20.7±2.
Croat Med J
December 2024
Iva Lončarić Kelečić, Department for Physical Therapy University Hospital Centre Zagreb Božidarevićeva 11, 10000 Zagreb, Croatia,
Aim: To ascertain whether Croatian respondents' knowledge on pain aligns with modern pain science, and determine the measurement properties of the Croatian version of the Concept of Pain Inventory for Adults (COPI-Adult).
Methods: A cross-sectional, online survey was used to collect the respondents' sociodemographic, clinical, and COPI-Adult (CRO) data (n = 509). A Pearson correlation coefficient test was used to assess the correlations between sociodemographic, clinical, and COPI-Adult (CRO) data.
Oncoimmunology
December 2025
Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.
Immune checkpoint blockade (ICB) has significantly improved the survival for many patients with advanced malignancy. However, fewer than 50% of patients benefit from ICB, highlighting the need for more effective immunotherapy options. High-dose interleukin-2 (HD IL-2) immunotherapy, which is approved for patients with metastatic melanoma and renal cell carcinoma, stimulates CD8 T cells and NK cells and can generate durable responses in a subset of patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!